Drugs Made In America Acquisition Corp. (DMAAU) Long-Term Investments (2025)

Drugs Made In America Acquisition (DMAAU) has 1 years of Long-Term Investments data on file, last reported at $239.9 million in Q4 2025.

• Quarterly Long-Term Investments changed N/A year-over-year to $239.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $239.9 million (changed N/A YoY) and the FY2025 annual result came in at $239.9 million, changed N/A from the prior year.
• Long-Term Investments grew to $239.9 million in Q4 2025, from $237.6 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $239.9 million in Q4 2025 to a low of $232.7 million in Q1 2025.